Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that impairs cognitive function, making early detection crucial for timely intervention. This study proposes a novel AD detection framework integrating gaze and head movement analysis via a dual-pathway convolutional neural network (CNN). Unlike conventional methods relying on linguistic, speech, or neuroimaging data, our approach leverages non-invasive video-based tracking, offering a more accessible and cost-effective solution to early AD detection. To enhance feature representation, we introduce GazeMap, a novel transformation converting 1D gaze and head pose time-series data into 2D spatial representations, effectively capturing both short- and long-term temporal interactions while mitigating missing or noisy data. The dual-pathway CNN processes gaze and head movement features separately before fusing them to improve diagnostic accuracy. We validated our framework using a clinical dataset (112 participants) from Konkuk University Hospital and an out-of-distribution dataset from senior centers and nursing homes. Our method achieved 91.09% accuracy on in-distribution data collected under controlled clinical settings, and 83.33% on out-of-distribution data from real-world scenarios, outperforming several time-series baseline models. Model performance was validated through cross-validation on in-distribution data and tested on an independent out-of-distribution dataset. Additionally, our gaze-saliency maps provide interpretable visualizations, revealing distinct AD-related gaze patterns.

Anomaly detection in multivariate time series is crucial for safeguarding the reliability of industrial, financial, and cybersecurity systems. However, conventional deep learning approaches often struggle with noise sensitivity and limited ability to capture complex intra- and inter-channel dynamics. To address these challenges, we propose a vision-inspired framework that transforms multivariate time series into multi-channel two-dimensional representations, allowing convolutional neural networks (CNNs) to extract local temporal patterns and spatial dependencies across variables. This representation enhances noise robustness and facilitates the modeling of periodic and evolving patterns often overlooked by 1D methods. To further improve performance, we incorporate Instance Normalization (IN), which preserves instance- and channel-specific variations critical for detecting subtle anomalies, and a Squeeze-and-Excitation (SE) block for adaptive channel weighting. Experiments on five benchmark datasets demonstrate that our approach consistently outperforms state-of-the-art methods, particularly under noisy conditions, highlighting its effectiveness and practicality for real-world anomaly detection tasks.

Accurate early screening of Alzheimer’s disease (AD) is crucial, yet traditional diagnostic methods are often limited by invasiveness or high costs. Therefore, there is a critical need for non-invasive biomarkers that enable precise and accessible screening. In this study, we propose a multi-modal digital biomarker framework designed to accurately detect AD by evaluating impairments across multiple cognitive domains, such as language, working memory, and visuospatial attention. By leveraging voice and video data, our approach significantly enhances user accessibility and real-world applicability. We validated the proposed framework using a dataset of 128 participants, comprising 77 healthy controls (HCs) and 51 patients with AD. While individual cognitive tasks yielded F1-scores ranging from 69.23% to 77.78% and sensitivities from 69.23% to 80.77%, our ensemble strategy significantly enhanced detection performance, achieving an F1-score of 83.64% and a sensitivity of 88.46%. These findings confirm that the proposed multi-modal digital biomarker framework, enhanced via ensembling, provides a highly accurate, scalable, and practical solution for the non-invasive screening and detection of AD.